Gan & Lee Pharmaceuticals.
SSE:603087.SS
55.83 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 984.867 | 800.342 | 930.113 | 746.385 | 554.069 | 696.037 | 675.906 | 671.766 | 558 | 475.381 | 402.09 | 144.808 | 689.991 | 1,108.969 | 1,027.645 | 926.826 | 548.604 | 1,170.147 | 984.331 | 737.488 | 469.916 | 1,041.772 | 894.484 | 530.561 | 428.245 | 490.221 | 490.221 |
| Cost of Revenue
| 228.91 | 213.265 | 204.143 | 223.292 | 152.249 | 240.794 | 158.534 | 171.825 | 150.831 | 135.044 | 117.774 | 92.632 | 60.353 | 111.193 | 113 | 117.118 | 54.801 | 115.956 | 79.475 | 70.407 | 40.815 | 93.687 | 68.706 | 42.042 | 33.54 | 38.951 | 38.951 |
| Gross Profit
| 755.958 | 587.077 | 725.971 | 523.093 | 401.82 | 455.243 | 517.372 | 499.94 | 407.169 | 340.337 | 284.316 | 52.176 | 629.638 | 997.776 | 914.645 | 809.708 | 493.803 | 1,054.191 | 904.856 | 667.082 | 429.101 | 948.085 | 825.778 | 488.519 | 394.704 | 451.27 | 451.27 |
| Gross Profit Ratio
| 0.768 | 0.734 | 0.781 | 0.701 | 0.725 | 0.654 | 0.765 | 0.744 | 0.73 | 0.716 | 0.707 | 0.36 | 0.913 | 0.9 | 0.89 | 0.874 | 0.9 | 0.901 | 0.919 | 0.905 | 0.913 | 0.91 | 0.923 | 0.921 | 0.922 | 0.921 | 0.921 |
| Reseach & Development Expenses
| 130.446 | 137.602 | 136.966 | 122.497 | 133.12 | 120.716 | 107.983 | 142.027 | 119.936 | 169.266 | 148.774 | 146.541 | 97.888 | 123.833 | 127.519 | 136.064 | 87.172 | 135.222 | 97.421 | 98.214 | 89.128 | 78.081 | 66.39 | 32.554 | 58.531 | 44.13 | 44.13 |
| General & Administrative Expenses
| 69.653 | -54.076 | 130.963 | -4.3 | 43.299 | -51.531 | 104.943 | -10.118 | 46.801 | -95.416 | 141.908 | -32.709 | 70.736 | -140.061 | 196.755 | -21.476 | 62.587 | -105.752 | 61.061 | -11.429 | 66.271 | -148.556 | 78.015 | 68.432 | 68.123 | 86.654 | 86.654 |
| Selling & Marketing Expenses
| 326.526 | -105.04 | 559.499 | 263.893 | 227.087 | 242.314 | 238.39 | 240.513 | 224.73 | 256.93 | 264.755 | 276.797 | 288.064 | 272.408 | 238.767 | 300.135 | 191.505 | 260.366 | 241.487 | 268.165 | 144.83 | 242.907 | 212.782 | 168.096 | 172.611 | 146.592 | 146.592 |
| SG&A
| 396.18 | -159.117 | 690.462 | 306.747 | 270.386 | 323.694 | 343.334 | 230.395 | 271.531 | 161.514 | 406.663 | 244.088 | 358.8 | 132.346 | 435.522 | 278.659 | 254.092 | 154.613 | 302.548 | 256.736 | 211.101 | 94.351 | 290.797 | 236.528 | 240.734 | 233.246 | 233.246 |
| Other Expenses
| -69.71 | 539.309 | -324.366 | -0.033 | 0.05 | -36.475 | -1.843 | -2.214 | 0.766 | 155.351 | -98.094 | 79.243 | 0.707 | 0.669 | -0.433 | -2.775 | -0.358 | -6.727 | 0.098 | 0.2 | -1.005 | 32.62 | -0.421 | -9.893 | -0.35 | 0 | 0 |
| Operating Expenses
| 456.915 | 517.795 | 503.062 | 429.277 | 403.456 | 480.885 | 389.861 | 437.108 | 392.233 | 486.131 | 457.343 | 469.872 | 457.395 | 459.895 | 454.492 | 501.526 | 340.457 | 477.79 | 406.084 | 445.985 | 295.613 | 367.286 | 361.129 | 269.74 | 301.145 | 235.504 | 235.504 |
| Operating Income
| 299.042 | 69.282 | 222.909 | 93.816 | -1.637 | -25.641 | 153.17 | 104.217 | 59.826 | -140.576 | -173.027 | -417.696 | 213.267 | 674.384 | 551.512 | 234.926 | 238.09 | 611.184 | 460.883 | 227.244 | 153.594 | 579.043 | 474.566 | 223.54 | 120.756 | 215.544 | 215.544 |
| Operating Income Ratio
| 0.304 | 0.087 | 0.24 | 0.126 | -0.003 | -0.037 | 0.227 | 0.155 | 0.107 | -0.296 | -0.43 | -2.884 | 0.309 | 0.608 | 0.537 | 0.253 | 0.434 | 0.522 | 0.468 | 0.308 | 0.327 | 0.556 | 0.531 | 0.421 | 0.282 | 0.44 | 0.44 |
| Total Other Income Expenses Net
| 61.349 | -2.502 | -0.157 | 1.059 | 115.197 | 20.761 | -1.843 | -2.214 | -2.135 | -8.992 | -2.341 | -2.302 | 0.034 | 0.669 | -0.433 | -2.775 | -0.358 | -6.727 | 0.098 | 0.2 | -1.005 | 10.227 | -0.421 | -9.893 | -0.35 | 4.153 | 4.153 |
| Income Before Tax
| 360.391 | 66.78 | 222.752 | 227.292 | 113.56 | -4.88 | 151.328 | 102.003 | 57.691 | -149.568 | -229.04 | -340.719 | 136.853 | 675.052 | 551.078 | 232.151 | 237.732 | 604.457 | 460.981 | 227.444 | 152.588 | 589.27 | 474.145 | 213.648 | 120.406 | 219.698 | 219.698 |
| Income Before Tax Ratio
| 0.366 | 0.083 | 0.239 | 0.305 | 0.205 | -0.007 | 0.224 | 0.152 | 0.103 | -0.315 | -0.57 | -2.353 | 0.198 | 0.609 | 0.536 | 0.25 | 0.433 | 0.517 | 0.468 | 0.308 | 0.325 | 0.566 | 0.53 | 0.403 | 0.281 | 0.448 | 0.448 |
| Income Tax Expense
| 48.472 | -40.618 | 14.391 | 24.392 | 17.556 | -78.636 | 19.007 | 17.071 | 8.467 | -123.857 | -12.841 | -29.814 | 23.556 | 93.708 | 52.437 | 49.459 | 47.654 | 59.951 | 82.424 | 42.908 | 29.477 | 83.473 | 80.37 | 43.606 | 22.739 | 33.972 | 33.972 |
| Net Income
| 311.919 | 107.399 | 208.361 | 202.9 | 96.004 | 73.593 | 132.321 | 84.932 | 49.223 | -25.71 | -216.199 | -310.905 | 113.298 | 581.344 | 498.641 | 182.692 | 190.078 | 544.506 | 378.557 | 184.536 | 123.112 | 505.797 | 393.775 | 170.042 | 97.667 | 185.728 | 185.728 |
| Net Income Ratio
| 0.317 | 0.134 | 0.224 | 0.272 | 0.173 | 0.106 | 0.196 | 0.126 | 0.088 | -0.054 | -0.538 | -2.147 | 0.164 | 0.524 | 0.485 | 0.197 | 0.346 | 0.465 | 0.385 | 0.25 | 0.262 | 0.486 | 0.44 | 0.32 | 0.228 | 0.379 | 0.379 |
| EPS
| 0.53 | 0.182 | 0.35 | 0.34 | 0.16 | 0.13 | 0.24 | 0.15 | 0.088 | -0.046 | -0.39 | -0.56 | 0.2 | 1.04 | 0.89 | 0.33 | 0.34 | 1.01 | 0.7 | 0.36 | 0.34 | 0.95 | 0.74 | 0.34 | 0.19 | 0.37 | 0.37 |
| EPS Diluted
| 0.53 | 0.182 | 0.35 | 0.34 | 0.16 | 0.13 | 0.24 | 0.15 | 0.088 | -0.046 | -0.39 | -0.56 | 0.2 | 1.04 | 0.89 | 0.33 | 0.34 | 1.01 | 0.7 | 0.36 | 0.34 | 0.95 | 0.74 | 0.34 | 0.19 | 0.37 | 0.37 |
| EBITDA
| 225.326 | 351.834 | 222.752 | 289.855 | 58.286 | 31.773 | 208.742 | 158.102 | 113.79 | -99.472 | -178.944 | -364.357 | 236.175 | 721.799 | 460.154 | 308.183 | 153.346 | 647.93 | 498.772 | 260.265 | 173.245 | 583.026 | 507.724 | 248.171 | 105.449 | 217.221 | 217.221 |
| EBITDA Ratio
| 0.229 | 0.44 | 0.239 | 0.388 | 0.105 | 0.046 | 0.309 | 0.235 | 0.204 | -0.209 | -0.445 | -2.516 | 0.342 | 0.651 | 0.448 | 0.333 | 0.28 | 0.554 | 0.507 | 0.353 | 0.369 | 0.56 | 0.568 | 0.468 | 0.246 | 0.443 | 0.443 |